MENU
+Compare
ABBV
Stock ticker: NYSE
AS OF
Jul 3 closing price
Price
$189.28
Change
-$1.47 (-0.77%)
Capitalization
322.43B

ABBV ABBVIE Forecast, Technical & Fundamental Analysis

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABBV with price predictions
Jul 03, 2025

ABBV in upward trend: price rose above 50-day moving average on July 02, 2025

ABBV moved above its 50-day moving average on July 02, 2025 date and that indicates a change from a downward trend to an upward trend. In of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where ABBV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on ABBV as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABBV just turned positive on July 02, 2025. Looking at past instances where ABBV's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for ABBV moved above the 200-day moving average on July 01, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 350 cases where ABBV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day moving average for ABBV crossed bearishly below the 50-day moving average on June 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABBV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (30.864) is very high in comparison to the industry average of (5.632). P/E Ratio (66.456) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.499) is also within normal values, averaging (3.004). Dividend Yield (0.033) settles around the average of (0.161) among similar stocks. P/S Ratio (5.900) is also within normal values, averaging (3.643).

View a ticker or compare two or three
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABBV is expected to report earnings to rise 30.89% to $3.22 per share on July 31

ABBVIE ABBV Stock Earnings Reports
Q2'25
Est.
$3.22
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.08
Q2'24
Missed
by $0.05
The last earnings report on April 25 showed earnings per share of $2.46, beating the estimate of $2.39. With 3.71M shares outstanding, the current market capitalization sits at 322.43B.
A.I.Advisor
published Dividends

ABBV paid dividends on May 15, 2025

ABBVIE ABBV Stock Dividends
А dividend of $1.64 per share was paid with a record date of May 15, 2025, and an ex-dividend date of April 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IQDG39.580.09
+0.22%
WisdomTree International Qual Div Gr ETF
VHT249.970.38
+0.15%
Vanguard Health Care ETF
XFEB33.96N/A
N/A
FT Vest US Eq Enh & Mod Buf ETF-Feb
PCCE12.70N/A
N/A
Polen Capital China Growth ETF
ETX18.17-0.05
-0.26%
EATON VANCE Municipal Income 2028 TERM TRUST

ABBV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-0.77%
PFE - ABBV
54%
Loosely correlated
+0.24%
AMGN - ABBV
48%
Loosely correlated
+0.47%
NVS - ABBV
45%
Loosely correlated
-1.54%
JNJ - ABBV
44%
Loosely correlated
N/A
GILD - ABBV
42%
Loosely correlated
+0.22%
More